CDTX vs TT · rev $1.3M vs P/E 36, rev $21.32B
Cidara Therapeutics Inc (CDTX) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
CDTX currently screens at market cap $6.96B. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the CDTX and TT stock pages for the full models.
Not investment advice.